|
DCUN1D4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.133800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.715600E-01 |
| Normal-vs-Stage2 |
5.305400E-01 |
| Normal-vs-Stage3 |
6.267800E-01 |
| Normal-vs-Stage4 |
4.053800E-01 |
| Stage1-vs-Stage2 |
4.973800E-01 |
| Stage1-vs-Stage3 |
6.553400E-01 |
| Stage1-vs-Stage4 |
2.516800E-01 |
| Stage2-vs-Stage3 |
3.977400E-01 |
| Stage2-vs-Stage4 |
6.413800E-01 |
| Stage3-vs-Stage4 |
2.444000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.665600E-01 |
| Normal-vs-AfricanAmerican |
8.786000E-01 |
| Normal-vs-Asian |
6.898700E-03 |
| Caucasian-vs-AfricanAmerican |
7.475200E-01 |
| Caucasian-vs-Asian |
1.749750E-02 |
| AfricanAmerican-vs-Asian |
3.298000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.237000E-01 |
| Normal-vs-Female |
4.535000E-01 |
| Male-vs-Female |
5.397400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.117800E-01 |
| Normal-vs-Extreme_Weight |
8.464400E-01 |
| Normal-vs-Obese |
4.872400E-01 |
| Normal-vs-Extreme_Obese |
3.799800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.406200E-01 |
| Normal_Weight-vs-Obese |
9.240400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.265000E-01 |
| Extreme_Weight-vs-Obese |
4.840000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.934600E-01 |
| Obese-vs-Extreme_Obese |
6.945800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.639600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.874100E-02 |
| Normal-vs-Age(61-80Yrs) |
3.793000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.072200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.497610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.832400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.639200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.059510E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.345000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.364800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.418010E-01 |
| Normal-VS-Type2 PRCC |
4.274800E-01 |
| Normal-VS-KIRP CIMP |
6.995400E-04 |
| Normal-VS-Unclassified PRCC |
8.653200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.826200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.583160E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.058400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.598000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.046200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.649580E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.958400E-01 |
| Normal-vs-N1 |
7.173600E-01 |
| Normal-vs-N2 |
8.270300E-02 |
| N0-vs-N1 |
4.781000E-01 |
| N0-vs-N2 |
1.430010E-01 |
| N1-vs-N2 |
1.485810E-01 |
|
|
